Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ABBOTT LABORATORIES | SENIOR VICE PRESIDENT | Common shares without par value | 45.1K | $4.87M | $108.00 | Mar 1, 2023 | Direct |
Axogen, Inc. | CEO and President, Director | Performance Stock Units | 450K | $3.46M | $7.68 | Aug 9, 2024 | Direct |
ABBOTT LABORATORIES | SENIOR VICE PRESIDENT | Option (right to buy) | 37.5K | Feb 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXGN | Axogen, Inc. | Aug 9, 2024 | 1 | $0 | 4 | Aug 9, 2024 | CEO and President, Director |
AXGN | Axogen, Inc. | Aug 9, 2024 | 0 | $0 | 3 | Aug 9, 2024 | CEO and President, Director |
ABT | ABBOTT LABORATORIES | Feb 28, 2023 | 2 | -$615K | 4 | Mar 2, 2023 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 17, 2023 | 2 | $0 | 4 | Feb 22, 2023 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Mar 8, 2022 | 1 | -$468K | 4 | Mar 10, 2022 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 28, 2022 | 2 | -$676K | 4 | Mar 2, 2022 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | SENIOR VICE PRESIDENT |
ABT | ABBOTT LABORATORIES | Jul 28, 2021 | 3 | -$1.23M | 4 | Jul 30, 2021 | SENIOR VICE PRESIDENT |